title: Changing the outcome of toxoplasmosis in bone marrow transplant recipients.
authors.forename: M
authors.initials: M
authors.lastname: Aoun
authors.forename: A
authors.initials: A
authors.lastname: Georgala
authors.forename: K
authors.initials: K
authors.lastname: Mboumi
authors.forename: J M
authors.initials: JM
authors.lastname: De Bruyne
authors.forename: V
authors.initials: V
authors.lastname: Duchateau
authors.forename: M
authors.initials: M
authors.lastname: Lemort
authors.forename: P
authors.initials: P
authors.lastname: Martiat
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D011739:Pyrimethamine / Q000627:therapeutic use; D016781:Toxoplasmosis, Cerebral / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D002981:Clindamycin; D011739:Pyrimethamine